The FDA's Bold New Vision: Could One Clinical Trial Be Enough for Drug Approval?

Virax Biolabs (VRAX) Stock Takes a Breather After a Wild Intraday Rally

A Glimmer of Hope for Hair Loss Sufferers: Cosmo Pharma's Breezula Delivers in Landmark Trial

A New Challenger Emerges: Could Viridian's Eye Disease Drug Outshine Amgen's Blockbuster Tepezza?

CVS Health Reaches $37.8 Million Settlement Over Allegations of Faulty Insulin Refills

ADC Therapeutics Shares Face Brutal Sell-Off After Disappointing Clinical Trial Results

A Beacon of Hope: Capricor's Cell Therapy Shows Remarkable Heart Improvements in Duchenne Patients

The Quest for Immortality: Billions Bet on Beating Time Itself

The Next Frontier: Unpacking the Future of Deep Tech

A Lasting Solution: Beating the Weight Regain Cycle Post-GLP-1s

Shattuck Labs Takes Flight: Goldman Sachs' Bold 'Buy' Rating Ignites Biotech Stock

A Bold Bet on the Future: Regeneron's $150M Investment in Gene Writing

A Beacon of Hope: Reviva Pharmaceuticals' Brilaroxazine Achieves Pivotal Milestones in Schizophrenia Treatment

Quantum Leap for Life Sciences: IonQ and CCRM Team Up to Revolutionize Biotech and Medicine

HeartBeam Shares Surge After Major FDA Approval

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

Kala Bio's Overnight Leap: Unpacking the Nearly 38% Stock Rocket

Novo Nordisk's Alzheimer's Trial: A Minor Blip for a Pharma Giant

Another Heartbreak in the Alzheimer's Fight: J&J's Posdinemab Stumbles

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

Madhya Pradesh Rolls Out the Red Carpet: Hyderabad Investors Hear the Call to the Heart of India

Venture Capital's Hot Spots: AI Infrastructure and Fintech Logistics Steal the Show

Texas Attorney General Takes On Pharma Giants Sanofi and Bristol Myers Squibb Over Alleged Plavix Warning Failures

When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote

A Glimmer of Hope? Novo Nordisk's GLP-1 Drug and the Alzheimer's Enigma

The Evolving Landscape of Biotech Innovation and Investment

The Jemperli Royalty Rumble: GSK's Tesaro Unit Takes AnaptysBio to Court

The Shifting Sands of Biotech M&A: Navigating a New Era with Veteran Insight

The Human Face of AI: How Recursion Pharma and Najat Khan Are Redefining Drug Discovery

A New Dawn: Why This Lung Cancer Drug Has Scientists (and Patients) Buzzing

The Unseen Hand: WuXi AppTec's Unstoppable Ascent Amidst Global Scrutiny

The Shifting Sands of Health: Navigating Biotech's Turbulent Waters and the GLP-1 Revolution

The Biotech Boom: Why a Frenzy of Mergers Signals Big Wins Ahead

The Unseen Battle: How Komzifti is Redrawing the Lines in Leukemia's Long War

The Infinite Game: Deepinder Goyal's Bold Leap into the Longevity Revolution

The Quiet Revolution: How One Pill Could Change the Game for Sickle Cell and Thalassemia Patients

The Quiet Hum of Hope and High Stakes: Unpacking the Future of Huntington's Treatment

The Siren Song of Scale: Why Big Pharma's Mega-Mergers So Often Fall Flat

Dragon's Roar in the Lab: How China's Biotech Ambitions Are Quietly Reshaping Global Pharma